Online Exclusive: Courting Controversy?

AstraZeneca is in full-on spin control mode following a potentially tarnishing interview that asserted the pharmaceutical giant was getting out of the drug-making business. According the September 17 edition of The Times of London ran an article titled "AstraZeneca to outsource manufacturing," which featured a key quote from Dave Smith, AstraZeneca's executive vice president of operations, which sent shock waves through the industry: "Manufacturing for AstraZeneca is not a core activity."

View Full Article